Andrea Krisai

Ms. Andrea Krisai

orcid

Research Focus & Metrics

Representative Publications

View All Publications
16 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
AKAndrea Krisai
Andrea Krisai
MWMichael Wiederstein
Michael Wiederstein
MFManuela Fuehrer
Manuela Fuehrer
SBSabine Baumgartner
Sabine Baumgartner
Henrich GrausgruberHenrich Grausgruber
Henrich Grausgruber
KLKathrin Lauter
Kathrin Lauter
Wheat and soybeans are widely consumed foods and important sources of food allergens, affecting approximately 0.4-1% and 0.3-3% globally, respectively. Although symptoms are often mild, reliable allergen detection is essential to prevent exposure and ensure effective risk control. Immunoassays employing monoclonal antibodies (mAB) enable component resolved analysis by specifically targeting individual major food allergens such as amylase-trypsin inhibitors (ATIs) and β-conglycinin (Gly m 5). Two ATI-specific mABs and two Gly m 5 subunit-specific mABs (α and β) were generated in Balb/c mice and characterized using wheat and soy protein extracts, purified protein fractions, self-produced recombinant allergens, and potentially cross-reactive protein extracts by competitive ELISA and Western Blot. Despite functional differences between small enzyme inhibitors (ATIs) and large storage proteins (Gly m 5), mABs enabled specific detection of both allergen types, demonstrating the versatility of antibody-based immunoassays and supporting improved food safety, labeling, and allergen management for wheat- and soy-allergic individuals.

Verified
Journal Article
Open access
PDF file
LCLisa Call
Lisa Call
TSThomas Svoboda
Thomas Svoboda
AKAndrea Krisai
Andrea Krisai
Tim HackerTim Hacker
Tim Hacker
KLKathrin Lauter
Kathrin Lauter
Henrich GrausgruberHenrich Grausgruber
Henrich Grausgruber
Wheat amylase–trypsin inhibitors (ATIs) are known for their allergenic properties, but their precise role in celiac disease and other wheat-related disorders remains unclear. Pure ATI preparations provide a basis for detailed biochemical and immunologic characterization; however, the complexity of isolating ATIs in the absence of other immunoreactive wheat proteins is an ongoing challenge. To address this limitation, bacterial and yeast heterologous expression systems were evaluated for the production of pure ATI preparations. While the synthesis of recombinant ATIs 0.28 and CM3 in Escherichia coli was challenging regarding protein solubility, promising results were observed for ATIs 0.19, CM1 and CM3 expressed in Pichia pastoris, both in terms of solubility and protein yields. The biochemical and immunoreactive properties of these recombinant ATIs were evaluated by SDS-PAGE, MALDI-TOF MS, LC-MS/MS, circular dichroism analysis, and in vitro inhibitory and immunoassays, and compared to native ATIs isolated from wheat. Our findings shed light on the difficulties in isolating pure ATIs and provide valuable insights into the potential impact of these proteins on human health. By using innovative expression systems, we aim to contribute to the detailed biochemical and immunogenic characterization of ATIs and improve the understanding of their role in wheat-related disorders and associated allergic responses.